Funding agencies: Michael J Fox Foundation; Mayo Clinic Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50NS072187); South African Medical Research Council.
Letters: New Observations
Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients
Article first published online: 6 SEP 2013
© 2013 Movement Disorder Society
Volume 28, Issue 14, pages 2039–2040, December 2013
How to Cite
Bardien, S., Blanckenberg, J., van der Merwe, L., Farrer, M. J. and Ross, O. A. (2013), Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients. Mov. Disord., 28: 2039–2040. doi: 10.1002/mds.25637
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 9 DEC 2013
- Article first published online: 6 SEP 2013
- Manuscript Accepted: 6 JUN 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 12 MAR 2013
No abstract is available for this article.